Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

David Becton

Concepts (167)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hemophilia A
2
2009
26
0.570
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2011
1030
0.500
 Why?
Leukemia, Myeloid, Acute
4
2010
202
0.380
 Why?
Osteosarcoma
2
2016
44
0.320
 Why?
von Willebrand Diseases
1
2009
25
0.310
 Why?
Hematology
1
2009
28
0.310
 Why?
Sclerotherapy
2
2020
46
0.310
 Why?
Antineoplastic Agents
5
2016
1219
0.280
 Why?
Vascular Malformations
2
2020
103
0.270
 Why?
Blood Coagulation Factor Inhibitors
1
2007
3
0.270
 Why?
Hemophilia B
1
2007
5
0.270
 Why?
Hemostasis, Surgical
1
2007
12
0.270
 Why?
Blood Coagulation Factors
1
2007
18
0.270
 Why?
Enoxaparin
1
2007
31
0.270
 Why?
Child, Preschool
13
2020
4056
0.260
 Why?
Blood Loss, Surgical
1
2007
69
0.260
 Why?
Venous Thrombosis
1
2007
90
0.250
 Why?
Cisplatin
3
2016
285
0.250
 Why?
Cyclosporine
1
2005
67
0.240
 Why?
Blood Coagulation Disorders
2
2020
38
0.230
 Why?
Leukemia
1
2005
67
0.230
 Why?
Hemostasis
2
2020
61
0.230
 Why?
Cladribine
1
2004
3
0.220
 Why?
Bone Regeneration
2
2016
70
0.220
 Why?
Histiocytosis, Langerhans-Cell
1
2004
33
0.210
 Why?
Retinoblastoma
1
2003
15
0.210
 Why?
Retinal Neoplasms
1
2003
13
0.210
 Why?
Infant
11
2018
3713
0.210
 Why?
Neoplasms
3
2012
1301
0.200
 Why?
Neoplasms, Second Primary
1
2003
77
0.190
 Why?
Child
14
2020
7218
0.190
 Why?
Bone Neoplasms
1
2003
184
0.180
 Why?
Thrombelastography
1
2020
27
0.170
 Why?
Adolescent
11
2020
6725
0.170
 Why?
Bleomycin
1
2018
38
0.140
 Why?
Down Syndrome
3
2008
93
0.140
 Why?
Antibiotics, Antineoplastic
1
2018
79
0.140
 Why?
Osteogenesis, Distraction
2
2016
78
0.130
 Why?
Piperazines
2
2016
125
0.130
 Why?
Leukemia, Megakaryoblastic, Acute
2
2006
6
0.130
 Why?
Leukemia, Myeloid
2
2008
40
0.130
 Why?
Humans
21
2020
52513
0.120
 Why?
Disease-Free Survival
5
2010
464
0.120
 Why?
Imidazoles
1
2016
124
0.120
 Why?
Remission Induction
4
2011
219
0.120
 Why?
Male
13
2020
26816
0.120
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2009
92
0.110
 Why?
Leukocyte Count
2
2005
73
0.110
 Why?
Receptors, Tumor Necrosis Factor, Type I
1
2013
38
0.110
 Why?
Survival Analysis
4
2010
673
0.100
 Why?
Doxorubicin
2
2005
241
0.100
 Why?
Cord Blood Stem Cell Transplantation
1
2011
9
0.090
 Why?
Sarcoma, Myeloid
1
2011
20
0.090
 Why?
Neutropenia
1
2012
115
0.090
 Why?
Heart Neoplasms
1
2011
32
0.090
 Why?
Treatment Outcome
7
2018
5480
0.090
 Why?
Core Binding Factors
1
2010
3
0.080
 Why?
Proto-Oncogene Proteins c-kit
1
2010
33
0.080
 Why?
Female
10
2020
28219
0.080
 Why?
Entamoebiasis
1
2009
2
0.080
 Why?
Diarrhea, Infantile
1
2009
5
0.080
 Why?
Liver Abscess
1
2009
5
0.080
 Why?
Listeriosis
1
2009
7
0.080
 Why?
Anemia, Aplastic
1
2009
11
0.080
 Why?
Platelet Transfusion
1
2009
33
0.080
 Why?
Histocompatibility Testing
1
2008
15
0.080
 Why?
Acute Lung Injury
1
2009
30
0.070
 Why?
HLA Antigens
1
2008
56
0.070
 Why?
Young Adult
5
2020
4326
0.070
 Why?
Abdominal Pain
1
2009
85
0.070
 Why?
Bone Marrow Transplantation
1
2008
113
0.070
 Why?
Hospitals, Pediatric
1
2009
243
0.070
 Why?
Retrospective Studies
6
2018
6661
0.070
 Why?
Adult
7
2020
14148
0.070
 Why?
Infusions, Intravenous
2
2004
221
0.060
 Why?
Cardiomyopathies
1
2008
124
0.060
 Why?
Mitolactol
1
2005
2
0.060
 Why?
GATA1 Transcription Factor
1
2005
7
0.060
 Why?
Karyotyping
1
2005
78
0.060
 Why?
Gene Expression Regulation, Neoplastic
2
2006
856
0.060
 Why?
Tamoxifen
1
2005
59
0.060
 Why?
Heart
1
2008
361
0.060
 Why?
Receptor Protein-Tyrosine Kinases
1
2004
52
0.050
 Why?
Proto-Oncogene Proteins
1
2004
151
0.050
 Why?
Immunosuppressive Agents
1
2005
250
0.050
 Why?
Humerus
1
2003
16
0.050
 Why?
Arkansas
1
2009
2029
0.050
 Why?
Tibia
1
2003
112
0.050
 Why?
Mutation
2
2010
1342
0.050
 Why?
Methotrexate
1
2003
77
0.050
 Why?
Survivors
1
2003
118
0.050
 Why?
Topotecan
1
2002
17
0.050
 Why?
Automation
1
2002
18
0.050
 Why?
Tumor Necrosis Factor-alpha
2
2013
395
0.040
 Why?
Blood Coagulation Tests
1
2020
18
0.040
 Why?
Dose-Response Relationship, Drug
1
2004
1372
0.040
 Why?
Blood Flow Velocity
1
2020
95
0.040
 Why?
Blood Coagulation
1
2020
62
0.040
 Why?
Follow-Up Studies
2
2018
2290
0.040
 Why?
Prognosis
3
2012
2115
0.040
 Why?
Mice, Inbred C57BL
2
2016
1897
0.040
 Why?
Gene Expression Profiling
1
2004
1108
0.040
 Why?
Hemorrhage
1
2020
224
0.040
 Why?
Daunorubicin
2
2008
13
0.030
 Why?
Cytarabine
2
2006
42
0.030
 Why?
Mice, Nude
1
2016
235
0.030
 Why?
Xenograft Model Antitumor Assays
1
2016
222
0.030
 Why?
Random Allocation
1
2016
285
0.030
 Why?
Acute Disease
2
2008
387
0.030
 Why?
Cluster Analysis
2
2005
233
0.030
 Why?
Prospective Studies
2
2012
2451
0.030
 Why?
Oligonucleotide Array Sequence Analysis
2
2005
412
0.030
 Why?
Interleukin-3
1
2012
12
0.020
 Why?
Calcitonin Gene-Related Peptide
1
2012
24
0.020
 Why?
Protein Precursors
1
2012
42
0.020
 Why?
Calcitonin
1
2012
30
0.020
 Why?
Sensitivity and Specificity
2
2006
882
0.020
 Why?
Interleukin-8
1
2012
86
0.020
 Why?
Interleukin-10
1
2012
84
0.020
 Why?
ROC Curve
1
2012
254
0.020
 Why?
Fatal Outcome
1
2011
195
0.020
 Why?
Mice, Knockout
1
2013
910
0.020
 Why?
Interleukin-6
1
2012
277
0.020
 Why?
Intensive Care Units
1
2012
235
0.020
 Why?
Animals
2
2016
13464
0.020
 Why?
Pilot Projects
1
2012
719
0.020
 Why?
Exons
1
2010
101
0.020
 Why?
Time Factors
2
2008
2997
0.020
 Why?
Opportunistic Infections
1
2009
56
0.020
 Why?
Echocardiography
1
2011
416
0.020
 Why?
Translocation, Genetic
1
2010
265
0.020
 Why?
Mitoxantrone
1
2008
9
0.020
 Why?
Proportional Hazards Models
1
2008
444
0.020
 Why?
Hospitalization
1
2012
749
0.020
 Why?
Recurrence
1
2008
681
0.020
 Why?
Genetic Predisposition to Disease
1
2010
527
0.020
 Why?
Prevalence
1
2010
1017
0.020
 Why?
Immunophenotyping
1
2006
117
0.020
 Why?
Tomography, X-Ray Computed
1
2011
1161
0.020
 Why?
Luciferases
1
2005
50
0.020
 Why?
Nucleic Acid Hybridization
1
2005
55
0.020
 Why?
Cell Membrane
1
2006
241
0.020
 Why?
Diagnosis, Differential
1
2009
1045
0.010
 Why?
DNA Primers
1
2005
206
0.010
 Why?
Middle Aged
1
2020
13081
0.010
 Why?
Tumor Cells, Cultured
1
2005
448
0.010
 Why?
Transfection
1
2005
368
0.010
 Why?
Core Binding Factor Alpha 3 Subunit
1
2004
1
0.010
 Why?
fms-Like Tyrosine Kinase 3
1
2004
20
0.010
 Why?
Magnetic Resonance Imaging
1
2011
1535
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
582
0.010
 Why?
Benzamides
1
2004
50
0.010
 Why?
Risk Assessment
1
2008
1348
0.010
 Why?
Risk Factors
1
2012
3951
0.010
 Why?
Mice
1
2013
5943
0.010
 Why?
Pyrimidines
1
2004
200
0.010
 Why?
Nuclear Proteins
1
2004
246
0.010
 Why?
DNA Helicases
1
2004
150
0.010
 Why?
DNA-Binding Proteins
1
2004
426
0.010
 Why?
Predictive Value of Tests
1
2004
949
0.010
 Why?
Drug Administration Schedule
1
2002
375
0.010
 Why?
Linear Models
1
2002
291
0.010
 Why?
Transcription Factors
1
2004
566
0.010
 Why?
Neutrophils
1
2002
148
0.010
 Why?
Analysis of Variance
1
2002
558
0.010
 Why?
Patient Selection
1
2002
266
0.010
 Why?
Infant, Newborn
1
2006
2884
0.010
 Why?
Becton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (167) concept(s)
_
Co-Authors Expand Description
See all (14) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department